Role of Akt/protein kinase B in the activity of transcriptional coactivator p300.

scientific article published on July 2004

Role of Akt/protein kinase B in the activity of transcriptional coactivator p300. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00018-004-4103-9
P698PubMed publication ID15224190
P5875ResearchGate publication ID8484617

P50authorBenjamin K TsangQ42713839
Jihong ChenQ42770849
Qiao LiQ42770858
P2093author name stringS S Halappanavar
J R St-Germain
P2860cites workUniversal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial InfarctionQ22242900
Pathophysiology of platelet resistance to anti-aggregating agents in insulin resistance and type 2 diabetes: implications for anti-aggregating therapyQ28196495
Myonecrosis after revascularization proceduresQ28261530
Peri-procedural myocardial injury: 2005 updateQ36263844
Plaque composition and clinical outcomes in acute coronary syndrome patients with metabolic syndrome or diabetesQ39639379
Relation of plasma glucose and endothelial function in a population-based multiethnic sample of subjects without diabetes mellitusQ39734568
The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination SurveyQ40582016
Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventionsQ40926303
Altered intracellular calcium and phorbol 12,13-dibutyrate binding to intact platelets in young obese subjectsQ42528977
The association between plaque characterization by CT angiography and post-procedural myocardial infarction in patients with elective stent implantationQ43175089
Usefulness of visceral obesity (waist/hip ratio) in predicting vascular endothelial function in healthy overweight adultsQ43812092
Frequency and long-term impact of myonecrosis after coronary stentingQ44012971
Platelet activation in obese women: role of inflammation and oxidant stressQ44184883
Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary interventionQ44620714
The angiographic and clinical outcomes after coronary stenting in patients with metabolic syndromeQ46627029
The correlation between lipid volume in the target lesion, measured by integrated backscatter intravascular ultrasound, and post-procedural myocardial infarction in patients with elective stent implantationQ47631189
AKT2 inhibition of cisplatin-induced JNK/p38 and Bax activation by phosphorylation of ASK1: implication of AKT2 in chemoresistanceQ47971254
Volumetric analysis of coronary plaque characterization in patients with metabolic syndrome using 64-slice multi-detector computed tomography.Q53280655
Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study.Q53891281
ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)—executive summary21When citing this document, the American College of Cardiology and the American Heart Association would appreciate the following citaQ58975824
Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndromeQ79753554
Impact of metabolic syndrome on tissue characteristics of angiographically mild to moderate coronary lesions integrated backscatter intravascular ultrasound studyQ79970237
Impact of plaque composition on cardiac troponin elevation after percutaneous coronary intervention: an ultrasound analysisQ84182447
Impact of metabolic syndrome on clinical outcomes after new generation drug-eluting stent implantation: the 'obesity paradox' phenomenon is still apparentQ84943581
Long-term effect of metabolic syndrome with and without diabetes mellitus on coronary revascularization in Japanese patients undergoing percutaneous coronary interventionQ85085084
P433issue13
P304page(s)1675-1683
P577publication date2004-07-01
P1433published inCellular and Molecular Life SciencesQ5058352
P1476titleRole of Akt/protein kinase B in the activity of transcriptional coactivator p300
P478volume61

Reverse relations

cites work (P2860)
Q33733125A combination of p300 and Braf expression in the diagnosis and prognosis of melanoma
Q34461031A systems biology analysis of the changes in gene expression via silencing of HPV-18 E1 expression in HeLa cells
Q37696081Activation of GATA4 gene expression at the early stage of cardiac specification
Q33925258Akt phosphorylation of p300 at Ser-1834 is essential for its histone acetyltransferase and transcriptional activity
Q33695448B56 regulatory subunit of protein phosphatase 2A mediates valproic acid-induced p300 degradation
Q34013630Beta-HPV 5 and 8 E6 promote p300 degradation by blocking AKT/p300 association
Q24537650Conditional knockout mice reveal distinct functions for the global transcriptional coactivators CBP and p300 in T-cell development
Q39528644Contribution of retinoid X receptor signaling to the specification of skeletal muscle lineage.
Q35010007Decreased expression of nuclear p300 is associated with disease progression and worse prognosis of melanoma patients
Q38937837Effects of histone deacetylase inhibitor valproic acid on skeletal myocyte development.
Q38797733Implication of retinoic acid receptor selective signaling in myogenic differentiation.
Q35192970Inhibition of HIV-1 Tat-mediated transcription by a coumarin derivative, BPRHIV001, through the Akt pathway.
Q39096573Inhibition of mTOR signalling potentiates the effects of trichostatin A in human gastric cancer cell lines by promoting histone acetylation
Q39699914Interplay of bromodomain and histone acetylation in the regulation of p300-dependent genes.
Q39748724Intracellular distribution of p300 and its differential recruitment to aggresomes in breast cancer
Q40556837Molecular Basis for the Regulation of Transcriptional Coactivator p300 in Myogenic Differentiation.
Q46422999Neuregulin-1 enhances differentiation of cardiomyocytes from embryonic stem cells
Q39017204PPARδ deficiency disrupts hypoxia-mediated tumorigenic potential of colon cancer cells
Q46619121Pharmacologic profiling of transcriptional targets deciphers promoter logic
Q39643895Promoter context determines the role of proteasome in ligand-dependent occupancy of retinoic acid responsive elements
Q38876354Regulation of MicroRNA 183 by Cyclooxygenase 2 in Liver Is DEAD-Box Helicase p68 (DDX5) Dependent: Role in Insulin Signaling.
Q42770821Regulation of Myf5 Early Enhancer by Histone Acetyltransferase p300 during Stem Cell Differentiation
Q42706407Resveratrol inhibits Staphylococcus aureus-induced TLR2/MyD88/NF-κB-dependent VCAM-1 expression in human lung epithelial cells
Q36548467Retinoid X Receptor-selective Signaling in the Regulation of Akt/Protein Kinase B Isoform-specific Expression
Q35568845Valproic acid and butyrate induce apoptosis in human cancer cells through inhibition of gene expression of Akt/protein kinase B
Q33913340WNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death
Q30422684p38 MAPK- and Akt-mediated p300 phosphorylation regulates its degradation to facilitate nucleotide excision repair

Search more.